Enteritis

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

...ts to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in...

DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation

...ts to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in...

Enteritis in Medical Dictionary

Enteritis

In medicine, enteritis refers to inflammation of the small intestine. It is most commonly caused by the ingestion of substances contaminated with pathogenic microorganisms. Symptoms include abdominal pain, cramping, diarrhea, dehydration and fever. See also inflammation of related organs of...

Radiation enteritis

Radiation enteritis is a functional disorder of the large ... Radiation enteritis . ... C, Allen H: The spectrum of radiation enteritis . Surgical considerations. ... Radiation enteritis is swelling (inflammation) of the lining of the small ... If the damage lasts only a short t...

E. coli enteritis

E. coli enteritis . Contents of this page: Illustrations. Alternative Names. Definition ... E. coli enteritis is a type of bacterial gastroenteritis. ... E. coli enteritis is a type of bacterial ... Recent family illness with E. coli . Recent family illness with vomiting ... o...

Campylobacter enteritis

General and clinical overview of the common form of food poisoning, including its symptoms, treatment, and potential complications. Fact sheet about the intestinal infection caused by eating or drinking food or water contaminated by Campylobacter jejuni bacteria. Campylobacter en...

Shigellosis

...et shigellosis is by direct oral contact with feces from an ... Includes definition, causes, symptoms, diagnosis, and treatment of Shigella enteritis also commonly known as Shigellosis . Basic information about Shigellosis , symptoms, diagnosis, treatment, and prevention. Information abou...

More>>

Enteritis in Biological News

New infant formula safety advice could prevent infant suffering

...equently isolated from the environment and various food products including infant formula. These bacteria have been associated with infant meningitis, enteritis and septicaemia, so prevention of infant's consumption is vital in maintaining their safety. These bugs will grow at 25C or 37C, but less so when t...

Enteritis in Biological Technology

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

...for the treatment and prevention of GVHD, the prevention of acute radiation enteritis and the treatment of Crohn's disease. "The FDA's decision to grant...ment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NI...

DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology

...ts to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

...begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in acute radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in...

DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments

...ts to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in...

DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments

...ts to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the second half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in...

DOR BioPharma Appoints Gregg Lapointe, CPA, MBA, to its Board of Directors

...ts to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the first half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in ...

DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer

...ts to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of DOR201 in radiation enteritis in the first half of 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in ...